Thomas Modine

Showing 1-16 of 16 articles

Interventions for valvular disease

Transapical transcatheter mitral valve implantation in patients with prior aortic valve replacement: a feasibility report

Taramasso M, Sorajja P, Dahle G, Dumonteil N, Schäfer U, Modine T, Overtchouk P, Coisne A, Nickenig G, Babaliaros V, Khattab A, Ludwig S, Conradi L

June 25, 2021 | 10.4244/EIJ-D-19-00947

How to eliminate mitral regurgitation definitively: the eternal dilemma?

Modine T, Ben-Ali W

April 20, 2021 | 10.4244/EIJV16I17A252

Interventions for valvular disease

Transaxillary compared with transcarotid access for TAVR: a propensity-matched comparison from a French multicentre registry

Debry N, Trimech T, Gandet T, Vincent F, Hysi I, Delhaye C, Cayla G, Koussa M, Juthier F, Leclercq F, Pécheux M, Ghostine S, Labreuche J, Modine T, Van Belle E

November 20, 2020 | 10.4244/EIJ-D-20-00117

Do we need alternative access in TAVR anymore?

Ben-Ali W, Overtchouk P, Modine T

February 7, 2020 | 10.4244/EIJV15I15A237

Will the PARTNER 3 Low Risk Trial change my practice?

McConkey H, Modine T, Latib A, Jüni P, Windecker S, Leon M

December 20, 2019 | 10.4244/EIJ-D-19-00847

Interventions for valvular disease

Transcatheter mitral valve replacement: factors associated with screening success and failure

Coisne A, Pontana F, Tchétché D, Richardson M, Longère B, Vahdat O, Berthoumieu P, Van Belle E, Rousse N, Lancellotti P, Montaigne D, Dumonteil N, Modine T

December 6, 2019 | 10.4244/EIJ-D-19-00444

Valvular heart disease: when does surgery remain the best option?

Overtchouk P, Vahanian A, Modine T

November 15, 2019 | 10.4244/EIJV15I10A157

Mitral valve regurgitation: a plea for transcatheter mitral valve replacement

Modine T, Prendergast B, Piazza N, Overtchouk P

September 20, 2019 | 10.4244/EIJV15I7A103

PCR London Valves Innovators Day 2017. Where will valve intervention be in 2025?

Dawkins S, Modine T, Windecker S, Piazza N, Prendergast B

November 20, 2017 | 10.4244/EIJV13I10A178

Transcatheter aortic valve implantation versus redo surgery for failing surgical aortic bioprostheses: a multicentre propensity score analysis

Spaziano M, Mylotte D, Thériault-Lauzier P, De Backer O, Søndergaard L, Bosmans J, Debry N, Modine T, Barbanti M, Tamburino C, Sinning J, Grube E, Nickenig G, Mellert F, Bleiziffer S, Lange R, de Varennes B, Lachapelle K, Martucci G, Piazza N

November 20, 2017 | 10.4244/EIJ-D-16-00303

Interventions for valvular disease

Repositionable percutaneous aortic valve implantation with the LOTUS valve: 30-day and 1-year outcomes in 250 high-risk surgical patients

Meredith I, Dumonteil N, Blackman D, Tchétché D, Walters D, Hildick-Smith D, Manoharan G, Harnek J, Worthley S, Rioufol G, Lefèvre T, Modine T, Van Mieghem N, Feldman T, Allocco D, Dawkins K

September 20, 2017 | 10.4244/EIJ-D-16-01024

Interventions for valvular disease

Insights into the need for permanent pacemaker following implantation of the repositionable LOTUS valve for transcatheter aortic valve replacement in 250 patients: results from the REPRISE II trial with extended cohort

Dumonteil N, Meredith I, Blackman D, Tchétché D, Hildick-Smith D, Spence M, Walters D, Harnek J, Worthley S, Rioufol G, Lefèvre T, Modine T, Van Mieghem N, Houle V, Allocco D, Dawkins K

September 20, 2017 | 10.4244/EIJ-D-16-01025

Interventions for valvular disease

Quantitative multi-slice computed tomography assessment of the mitral valvular complex for transcatheter mitral valve interventions part 1: systematic measurement methodology and inter-observer variability

Thériault-Lauzier P, Mylotte D, Dorfmeister M, Spaziano M, Andalib A, Mamane S, Chetrit M, Blanke P, Cecere R, Buithieu J, Martucci G, Tchétché D, Modine T, Van Mieghem N, Lange R, Windecker S, Bilodeau L, Leipsic J, Piazza N

October 10, 2016 | 10.4244/EIJY15M11_09

Interventions for valvular disease

TAVI device selection: time for a patient-specific approach

Lee M, Modine T, Piazza N, Mylotte D

September 18, 2016 | 10.4244/EIJV12SYA9

Interventions for valvular disease

How should I treat a mitral prosthesis rupture after left ventricular assist device implantation?

Santise G, Nardella S, Leonetti S, Buioni D, Missiroli B, Di Marzio E, Maselli D, Mylotte D, Piazza N, Modine T, De Marco F, Garatti A, Testa L, Bedogni F

July 20, 2016 | 10.4244/EIJV12I4A89

Update on the need for a permanent pacemaker after transcatheter aortic valve implantation using the CoreValve® Accutrak™ system

Tchétché D, Modine T, Farah B, Vahdat O, Sudre A, Koussa M, Lereun C, Nejjari M, Choby M, Rosencher J, Sorbets E, Fajadet J

September 28, 2012 | 10.4244/EIJV8I5A86

Latest news

NEW ISSUE

State of the Art on ViV-TAVI; Transseptal Punctures; Endovascular Closure and TF-TAVI; Percutaneous PVL Closure: Long-Term Outcomes; and more

October 20, 2021

STATE OF THE ART

Valve-in-valve TAVI: a practical overview

Giuseppe Tarantini et al.

October 20, 2021

AHEAD OF PRINT

TAVI in younger (<70 years old) patients: the AMTRAC registry

Guy Witberg et al.

October 22, 2021

AHEAD OF PRINT

Impact of LVOT calcification in transfemoral TAVI patients

L. Waldschmidt et al.

Impact of preprocedural biological markers on 10-year mortality in the SYNTAXES trial

Hironori Hara et al.

October 22, 2021

AHEAD OF PRINT

Serum caffeine causes adenosine-induced FFR overestimation

Hideaki Tanaka et al.